OLIVIA HOUCHINS: Open Payments
NPI 1104452010 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 27 payments from 7 companies in 2025. Trend: 2023 $559 · 2024 $497 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $282 |
| Vanda Pharmaceuticals Inc. | 5 | $143 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: COBENFY, FANAPT, AUSTEDO XR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA, CAPLYTA.
Industry payments across VA — which companies pay providers there.
